Página de ensayos clínicos Nct

Clinical Trial Results:
An exploratory, randomised, double-blind, placebo-controlled, parallel group, pilot study to assess the analgesic efficacy of oxycodone/naloxone prolonged release tablets (OXN PR) compared to placebo in opioid-naïve Subjects suffering from severe pain due to Bladder Pain Syndrome.

Summary
EudraCT number
2009-018118-21
Trial protocol
DE   HU   CZ   GB  
Global completion date
25 Mar 2013

Paediatric regulatory details
Is the trial part of an agreed EMA paediatric investigation plan?
No
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006?
No
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006?
No

Results information
Results version number
v1(current)
This version publication date
28 May 2016
First version publication date
28 May 2016
Other versions
Summary report(s)
OXN2503 CSR synopsis
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.
3
Suscribir